Integrating pharmacogenetic testing into primary care.
作者： Susanne B. Haga
DOI: 10.1080/23808993.2017.1398046
关键词:
摘要: Introduction: Pharmacogenetic (PGx) testing has greatly expanded due to enhanced understanding of the role genes in drug response and advances DNA-based technology development. As man...
sci-hub.se 参考文章(133)
Stephen D. Krau, Cytochrome p450 part 2: what nurses need to know about the cytochrome p450 family systems Nursing Clinics of North America. ,vol. 48, pp. 681- 696 ,(2013) , 10.1016/J.CNUR.2013.09.003
Rebecca K. Marcus, Jennifer L. Geurts, Jessica A. Grzybowski, Kiran K. Turaga, T. Clark Gamblin, Kimberly A. Strong, Fabian M. Johnston, Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines Familial Cancer. ,vol. 14, pp. 641- 649 ,(2015) , 10.1007/S10689-015-9817-9
Jose de Leon, Margaret T. Susce, Maria Johnson, Mike Hardin, Lorraine Maw, Alison Shao, Antonette C.P. Allen, Francis A. Chiafari, Grantland Hillman, D. Michele Nikoloff, DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping CNS Spectrums. ,vol. 14, pp. 19- 35 ,(2009) , 10.1017/S1092852900020022
Andrea Desmond, Allison W. Kurian, Michele Gabree, Meredith A. Mills, Michael J. Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M. Shannon, Nadine Tung, James M. Ford, Stephen E. Lincoln, Leif W. Ellisen, Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA Oncology. ,vol. 1, pp. 943- 951 ,(2015) , 10.1001/JAMAONCOL.2015.2690
Kathleen S. Brennan, Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses Journal of the American Association of Nurse Practitioners. ,vol. 27, pp. 246- 255 ,(2015) , 10.1002/2327-6924.12237
Amy L. Kaufman, Jared Spitz, Michael Jacobs, Matthew Sorrentino, Shennin Yuen, Keith Danahey, Donald Saner, Teri E. Klein, Russ B. Altman, Mark J. Ratain, Peter H. O’Donnell, Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs Mayo Clinic Proceedings. ,vol. 90, pp. 716- 729 ,(2015) , 10.1016/J.MAYOCP.2015.03.016
Basima Almomani, Ahmed F Hawwa, Nicola A Goodfellow, Jeffrey S Millership, James C McElnay, Pharmacogenetics and the print media:what is the public told? BMC Medical Genetics. ,vol. 16, pp. 32- 32 ,(2015) , 10.1186/S12881-015-0172-3
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R. Blazer, Jeffrey N. Weitzel, Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management Frontiers in Oncology. ,vol. 5, pp. 208- 208 ,(2015) , 10.3389/FONC.2015.00208
Kenneth D. Levy, Victoria M. Pratt, Todd C. Skaar, Gail H. Vance, David A. Flockhart, FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing. The Journal of Clinical Pharmacology. ,vol. 55, pp. 725- 727 ,(2015) , 10.1002/JCPH.492
E. Hillebrenner, E. Litwack, P. Bradley, K. Donigan, T. Lowe, K. Serrano, K. Kelm, E. Mansfield, A. Gutierrez, FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care The Journal of Clinical Pharmacology. ,vol. 55, pp. 728- 730 ,(2015) , 10.1002/JCPH.521